Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine‐Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study

The objective of this study was to evaluate the relative bioavailability of olanzapine in 3 olanzapine‐containing tablet formulations. ALKS 3831 is a fixed‐dose combination of olanzapine (OLZ, an atypical antipsychotic) and samidorphan (SAM, a μ‐opioid receptor antagonist with low intrinsic activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, McDonnell, David, Liu, Jianjun, von Moltke, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585851/
https://www.ncbi.nlm.nih.gov/pubmed/30059196
http://dx.doi.org/10.1002/cpdd.601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585851/
https://www.ncbi.nlm.nih.gov/pubmed/30059196
http://dx.doi.org/10.1002/cpdd.601

Ejemplares similares